BASi
 
1Q Revenues: $4.9 million (-16%)

1Q Loss: $506,000 (earnings were $182,000 1Q15)

Comments: Service revenue for the quarter decreased 8% to $4.1 million. Increased preclinical services revenue was more than offset by lower other lab services revenue, due to fewer bioequivalence studies, and a decline in Bioanalytical revenue.Products sales were down 42% in the quarter to $840,000, due to lower sales of Culex automated in-vivo sampling systems and analytical instruments.